CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 256 filers reported holding CYTOKINETICS INC in Q3 2023. The put-call ratio across all filers is 2.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $297,015 | -31.1% | 10,082 | -17.7% | 0.00% | 0.0% |
Q2 2023 | $430,831 | 0.0% | 12,243 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $430,831 | -28.0% | 12,243 | -6.3% | 0.00% | -50.0% |
Q4 2022 | $598,684 | -7.2% | 13,066 | -1.9% | 0.00% | 0.0% |
Q3 2022 | $645,000 | -13.2% | 13,313 | -29.7% | 0.00% | 0.0% |
Q2 2022 | $743,000 | +64.7% | 18,924 | +54.2% | 0.00% | +100.0% |
Q1 2022 | $451,000 | -18.1% | 12,270 | +1.4% | 0.00% | -33.3% |
Q4 2021 | $551,000 | +32.5% | 12,106 | +3.9% | 0.00% | +50.0% |
Q3 2021 | $416,000 | +1881.0% | 11,647 | +1086.0% | 0.00% | – |
Q3 2020 | $21,000 | 0.0% | 982 | +8.0% | 0.00% | – |
Q2 2020 | $21,000 | +425.0% | 909 | +109.0% | 0.00% | – |
Q1 2020 | $4,000 | 0.0% | 435 | 0.0% | 0.00% | – |
Q4 2019 | $4,000 | -33.3% | 435 | -28.5% | 0.00% | – |
Q3 2019 | $6,000 | +20.0% | 608 | +21.4% | 0.00% | – |
Q2 2019 | $5,000 | +150.0% | 501 | +75.2% | 0.00% | – |
Q1 2019 | $2,000 | +100.0% | 286 | +27.7% | 0.00% | – |
Q4 2018 | $1,000 | – | 224 | +154.5% | 0.00% | – |
Q3 2016 | $0 | – | 88 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management IV, LLC | 1,723,170 | $13,940,000 | 5.01% |
RP Management, LLC | 875,656 | $7,084,000 | 3.54% |
BVF INC/IL | 3,801,817 | $30,757,000 | 3.44% |
DAFNA Capital Management LLC | 400,294 | $3,238,000 | 1.40% |
Virtus ETF Advisers LLC | 33,758 | $273,000 | 0.58% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 67,352 | $545,000 | 0.44% |
WASATCH ADVISORS LP | 3,188,487 | $25,795,000 | 0.28% |
LANSDOWNE PARTNERS (UK) LLP | 1,459,706 | $11,809,000 | 0.26% |
Campbell & CO Investment Adviser LLC | 43,844 | $355,000 | 0.18% |
Fosun International Ltd | 239,792 | $1,981,000 | 0.13% |